参会转化中心 详细 >>
上交转化医学研究院干细胞再生医学转化基地
上海交大、九院-数字医学临床转化中心
瑞金医院血液学研究所
上海市第六人民医院内分泌科
复旦大学附属中山医院
同济大学东方转化医学研究中心
同济医院转化医学中心
长海医院临床与转化医学中心
中国科学院－第二军医大学转化医学研究院
上海中医药大学附属龙华医院
Bahija Jallal
Dr. Bahija Jallal
Dr. Bahija Jallal Executive Vice President, Research & Development ,MedImmune
Dr. Bahija Jallal is Executive Vice President of Research and Development with oversight for research, development and clinical activities based at MedImmune's Gaithersburg, California and Cambridge, UK sites. Dr. Jallal joined MedImmune as vice president, translational sciences, in March 2006 and has been in positions of increasing responsibility.
Dr. Jallal has guided the MedImmune R&D organization through unprecedented growth and expansion of its biologics pipeline from 40 drugs to more than 140. She inspires creativity, out-of-the-box thinking and a dedication to scientific excellence to the more than 2,500 employees in her organization. As part of the MedImmune Executive Team and parent company AstraZeneca Research and Development Leadership Team, Dr. Jallal is passionate about leading and shaping MedImmune's rich pipeline of drugs targeting cancer, infections, respiratory and inflammatory diseases, cardio-vascular and gastrointestinal disorders and pain to ultimately develop new medicines for patients.
Dr. Jallal participated in Maryland's Governor O'Malley's Trade Mission to India where she represented the life sciences. Dr. Jallal is a member of the Board of Directors of the University of Maryland Health Sciences Research Park Corporation and has represented the life sciences industry at Maryland's Governor O'Malley's Trade Mission. She has authored over 60 peer-reviewed publications and has over 15 patents. She is a member of multiple research associations and organizations promoting women in science. In 2011 she was named one of FierceBiotech's Women in Biotech.
Prior to joining MedImmune, Dr. Jallal worked with Chiron Corporation where she served as vice president, drug assessment and development, and successfully established the company's translational medicine group. Prior to Chiron Corporation, she worked at Sugen, Inc. where she held positions of increasing responsibility leading to senior director, research.
Dr. Jallal received a master's degree in biology from the Universite de Paris VII in France, and her doctorate in physiology from the University of Pierre & Marie Curie in Paris. She conducted her postdoctoral research at the Max-Planck Institute of Biochemistry in Martinsried, Germany.
编辑: xy 作者:丁香园通讯员
以下网友留言只代表网友个人观点，不代表网站观点
